In ‘truly bizarre’ situation, FDA, DOJ and federal judge differ on ‘Plan B’ pill sale to teens
By Martha Neil
May 2, 2013, 11:15 am CDT
Add a Comment
We welcome your comments, but please adhere to our comment policy.
Commenting has expired on this post.